Getting genetic counseling can encourage people at risk for hereditary transthyretin amyloidosis to have genetic testing and know they have…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Rising levels of a protein called neurofilament light chain (NfL) in the blood may indicate nerve damage due to…
Tegsedi (inotersen) safely and effectively slowed the progression of polyneuropathy, or damage to multiple nerves, when taken for up…
HATTR-PN
NewsMuscle ultrasound may help monitor FAP severity
The parameters of muscle ultrasound, which uses sound waves to make pictures of muscles, are significantly different among people with…
A study of people carrying mutations known to cause familial amyloid polyneuropathy (FAP) found that those with disease symptoms…
Abnormalities in capillaries, or very small blood vessels, and inflammation from increased blood clotting may contribute to nerve damage, or…
Running a genetic screening may help to diagnose familial amyloid polyneuropathy (FAP) among people with sensory-motor polyneuropathy — damage…
New 15-year data from a global study involving more than 6,000 people with ATTR amyloidosis, an umbrella term for conditions…
A little more than a year of treatment with eplontersen was found to stabilize or even improve the heart’s…
HATTR-PN
NewsBlood NfL levels may mark the onset of symptoms in FAP
Blood levels of neurofilament light chain (NfL) — a marker of nerve cell damage — can separate people with symptoms…